| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
9,592 |
8,174 |
$1.69M |
| J0178 |
Injection, aflibercept, 1 mg |
1,722 |
1,518 |
$843K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
1,372 |
1,205 |
$364K |
| 92134 |
|
14,529 |
13,418 |
$335K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,945 |
1,678 |
$117K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
234 |
195 |
$97K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,099 |
3,079 |
$88K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
3,231 |
3,167 |
$86K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,264 |
1,260 |
$76K |
| 92226 |
|
2,875 |
1,813 |
$73K |
| 92202 |
|
4,483 |
4,392 |
$41K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
669 |
662 |
$40K |
| 92235 |
|
622 |
622 |
$36K |
| 92201 |
|
1,622 |
1,488 |
$31K |
| J7999 |
Compounded drug, not otherwise classified |
739 |
676 |
$27K |
| 4040F |
|
3,279 |
2,856 |
$24K |
| 1036F |
|
3,047 |
2,651 |
$22K |
| 92225 |
|
684 |
375 |
$19K |
| 67228 |
|
49 |
37 |
$18K |
| 5010F |
|
1,465 |
1,194 |
$16K |
| 2022F |
|
1,737 |
1,452 |
$13K |
| 92250 |
|
483 |
479 |
$13K |
| G8482 |
Influenza immunization administered or previously received |
2,135 |
1,855 |
$10K |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
826 |
731 |
$9K |
| 2021F |
|
621 |
460 |
$8K |
| 4177F |
|
1,185 |
1,063 |
$7K |
| 76512 |
|
69 |
59 |
$2K |
| 3072F |
|
209 |
189 |
$38.43 |